Endast för hälso-och sjukvårdspersonal

Produktresumé för våra godkända läkemedel på FASS:  Breyanzi® (lisokabtagen-maraleucel)

From Clinical Study To Clinical Practice with CAR-T

Varighet: cirka 9 minuter

Professor Stephan Mielke, department of hematology and cell therapy at Karolinska university hospital in Stockholm, shares insights from their CAST team, what patients are appropriate for CAR-T, the journey from participating in clinical trials to clinical practice with CAR-T and how the treatment landscape in 2nd and 3rd line is changing in DLBCL.

Related videos

Nytt nationellt vårdprogram aggressivt B-cellslymfom – fokus på CAR-T

How can we improve outcomes for patients with R/R LBCL?

News

Learn about current topics in hematology, such as new research data, news from events, congresses and more.

Education

Find past and upcoming educational events and access learning tools such as webinars, training videos and expert interviews.

HE-SE-2500012 FEB25 video/ 2009-SE-2500035 01/2026